Akso Health GroupAHG +0.66%36 EBIT per Share is $-0.01 as of Sep. 2025. GuruFocus rates AHG with a GF Score™ of 36/100 and a GF Value™ of $0.47 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 106 Medical Distribution companies, Akso Health Group ranks better than 90.57% on this metric.
Akso Health Group's EBIT per Share for the
six
months ended in Sep. 2025 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was 51.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 41.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Akso Health Group's EBIT per Share or its related term are showing as below:
AHG'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -12.7 Med: 23.8 Max: 51.7
Current: 51.7
During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of Akso Health Group was 51.70% per year. The lowest was -12.70% per year. And the median was 23.80% per year.
AHG's 3-Year EBIT Growth Rate is ranked better than 90.57% of 106
companies
in the Medical Distribution industry
Industry Median: 4.1
vs AHG: 51.70
Akso Health Group (NAS:AHG) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Akso Health Group EBIT per Share Related Terms
Akso Health Group EBIT per Share Historical Data
* Premium members only.
The historical data trend for Akso Health Group's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akso Health Group (AHG) has a EBIT per Share of $-0.01 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Akso Health Group and its competitors. According to the industry distribution chart, Akso Health Group ranks #10 out of 106 companies in the Medical Distribution industry, placing it in the top 9.4%.
Is Akso Health Group's EBIT per Share too high?
Akso Health Group's current EBIT per Share is $-0.01. Based on the distribution chart, Akso Health Group ranks #10 out of 106 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Akso Health Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's EBIT per Share compare to ACH and FOCL?
According to the Medical Distribution industry distribution chart, Akso Health Group ranks #10 out of 106 companies for EBIT per Share. This places Akso Health Group in the top 9% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 4.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.10, based on 106 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Akso Health Group and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akso Health Group's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Based on GuruFocus' analysis, Akso Health Group (AHG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.47, compared to a current price of $1.52 — trading 223.4% above its estimated fair value. The current EBIT per Share is $-0.01. Akso Health Group's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Akso Health Group (AHG), the current EBIT per Share is $-0.01 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akso Health Group (AHG) Overvalued in 2026?
Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued.
The current stock price of $1.52 is trading 223.4% above its estimated GF Value™ of $0.47.
GuruFocus considers Akso Health Group to be Significantly Overvalued.
Key valuation signals for AHG:
EBIT per Share: $-0.01
GF Value™: $0.47 vs. price of $1.52 (223.4% above fair value)
No single metric tells the full story. See the AHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
36GF Score
Get the complete analysis for AHG
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHG has been successfully added to your 
